News

$2.8 Million NIH Grant Advances Hearing Loss Research

Published Date:

Aug. 26, 2015 - Southern Illinois University School of Medicine researcher Kathleen Campbell, PhD, professor in the Department of Surgery, has secured a five-year grant from the National Institutes of Health (NIH) to advance her decades of research in hearing loss prevention and treatment. The total budget for the project is $2.8 million. 

This grant will determine the optimal dosing level of D-methionine (D-met), a compound that has been shown to prevent hearing loss. D-met is an amino acid that has been found to protect against noise-induced hearing loss and ototoxicity, or damage to the ear caused by some antibiotics and platinum-based chemotherapy agents, such as cisplatin.


"With the help of our current Department of Defense lab funding, we have found that the optimal D-met protection is dose-sensitive, with higher or lower dosing reducing efficacy," said Campbell. "Thus, with this grant, we will determine the optimal dosing level as well as when that dose will be most effective." If successful, the clinical use of D-met otoprotection will move one step closer to FDA approval.

According to Campbell, D-met can provide both "rescue" and protective functions in preventing permanent noise-induced hearing loss.

"We've found that D-met can provide this 'rescue' protection very effectively if first initiated up to 24 hours after noise exposure and with lesser protection up to 36 hours after," Campbell said. "Rescue therapy would be of great clinical use after unexpected noise exposures, such as car airbag deployment, high sound level concerts, fireworks, emergency work or battlefield weaponry," said Campbell.
Similarly, Campbell has discovered D-met's ability to prevent hearing loss if given before noise exposure. 

"A patient could take D-met a day or perhaps a few days prior to noise exposure and still be protected without carrying the otoprotective agent during the noise exposure," Campbell said. The preventative and rescue functions of D-met could prove useful to special operation military forces, hunters, SWAT teams, firefighters and other emergency personnel.

In addition to determining the optimal dose of D-met, Campbell will examine how specific biomarkers impact the dose's effectiveness.

Campbell's research, which has been previously funded by the Department of Defense, Veterans Administration, Illinois Department of Health and the National Institutes of Health, has secured more than $11 million in funding since she joined SIU School of Medicine in 1989. Named a university-wide Distinguished Scholar in 2014, Campbell has been featured in numerous well-known publications, including The Wall Street Journal, Popular Science and The New York Times.

Research reported in this press release is supported by the National Institutes of Health under award number 1R01DC014549-01.

More from SIU News

Maci Burgener and Evan Beilfuss

Baby med school on steroids leads to hometown health care

For many aspiring medical professionals, the journey to becoming a physician can feel like navigating a complex maze. For Evan Beilfuss and Maci Burgener, their paths converged at SIU School of
Aida lab

Alzheimer’s and cancer experts collaborate to study chemobrain

Research study will explore possible link with cytokine profiles, differences between men and women The Smith Alzheimer’s Center and Simmons Cancer Institute are teaming up to better understand the
Mandy Hagen

Strength in recovery: Letting lived experience lead the way

When Mandy Hagen stepped onstage to accept the Rising Star Award in addiction services, it marked a full-circle moment. Once unsure whether she deserved a seat at the table, today she’s leading recovery efforts across four counties in southern Illinois and inspiring others to find their way forward.